These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 8851250)
21. Thermal desorption counter-flow introduction atmospheric pressure chemical ionization for direct mass spectrometry of ecstasy tablets. Inoue H; Hashimoto H; Watanabe S; Iwata YT; Kanamori T; Miyaguchi H; Tsujikawa K; Kuwayama K; Tachi N; Uetake N J Mass Spectrom; 2009 Sep; 44(9):1300-7. PubMed ID: 19565470 [TBL] [Abstract][Full Text] [Related]
22. Determination of a new designer drug, N-hydroxy-3,4-methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography-tandem mass spectrometry. Kikura-Hanajiri R; Kawamura M; Miyajima A; Sunouchi M; Goda Y Forensic Sci Int; 2010 May; 198(1-3):62-9. PubMed ID: 20299167 [TBL] [Abstract][Full Text] [Related]
23. Microwave-induced rapid preparation of fluoro-derivatives of amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine for GC-MS confirmation assays. Thompson WC; Dasgupta A Clin Chem; 1994 Sep; 40(9):1703-6. PubMed ID: 7915216 [TBL] [Abstract][Full Text] [Related]
24. Simultaneous determination of amphetamine-type stimulants and cannabinoids in fingernails by gas chromatography-mass spectrometry. Kim JY; Cheong JC; Kim MK; Lee JI; In MK Arch Pharm Res; 2008 Jun; 31(6):805-13. PubMed ID: 18563365 [TBL] [Abstract][Full Text] [Related]
25. The designer drug situation in Ibiza. Lora-Tamayo C; Tena T; Rodríguez A; Moreno D; Sancho JR; Enseñat P; Muela F Forensic Sci Int; 2004 Mar; 140(2-3):195-206. PubMed ID: 15036441 [TBL] [Abstract][Full Text] [Related]
26. Determination of MDMA, MDA, MDEA and MBDB in oral fluid using high performance liquid chromatography with native fluorescence detection. Concheiro M; de Castro A; Quintela O; López-Rivadulla M; Cruz A Forensic Sci Int; 2005 Jun; 150(2-3):221-6. PubMed ID: 15944063 [TBL] [Abstract][Full Text] [Related]
27. Determination of amphetamine and methylenedioxy-amphetamine-derivatives in hair. Röhrich J; Kauert G Forensic Sci Int; 1997 Jan; 84(1-3):179-88. PubMed ID: 9042723 [TBL] [Abstract][Full Text] [Related]
28. Electrochemical and spectroscopic characterisation of amphetamine-like drugs: application to the screening of 3,4-methylenedioxymethamphetamine (MDMA) and its synthetic precursors. Milhazes N; Martins P; Uriarte E; Garrido J; Calheiros R; Marques MP; Borges F Anal Chim Acta; 2007 Jul; 596(2):231-41. PubMed ID: 17631101 [TBL] [Abstract][Full Text] [Related]
29. Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation. Meyer MR; Maurer HH Chem Res Toxicol; 2009 Jun; 22(6):1205-11. PubMed ID: 19462939 [TBL] [Abstract][Full Text] [Related]
30. Adam and Eve make love. Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, "Eve") and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain. Tucker G Hum Exp Toxicol; 1996 May; 15(5):455-7. PubMed ID: 8735473 [No Abstract] [Full Text] [Related]
31. The use of supercritical fluid extraction for the determination of amphetamines in hair. Allen DL; Oliver JS Forensic Sci Int; 2000 Jan; 107(1-3):191-9. PubMed ID: 10689572 [TBL] [Abstract][Full Text] [Related]
33. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong. Cheng WC; Poon NL; Chan MF J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267 [TBL] [Abstract][Full Text] [Related]
34. Quantification of MDMA and MDA in abusers' hair samples by semi-micro column HPLC with fluorescence detection. Nakamura S; Tomita M; Wada M; Chung H; Kuroda N; Nakashima K Biomed Chromatogr; 2006; 20(6-7):622-7. PubMed ID: 16779783 [TBL] [Abstract][Full Text] [Related]
35. Estimation of community-wide drugs use via stereoselective profiling of sewage. Kasprzyk-Hordern B; Baker DR Sci Total Environ; 2012 Apr; 423():142-50. PubMed ID: 22404981 [TBL] [Abstract][Full Text] [Related]
36. Microbial transformation of 3,4-methylenedioxy-N-methylamphetamine and 3,4-methylenedioxyamphetamine. Foster BC; Wilson DL; Marwood T; Ethier JC; Zamecnik J Can J Microbiol; 1996 Aug; 42(8):851-4. PubMed ID: 22049999 [TBL] [Abstract][Full Text] [Related]
37. Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats. Meyer A; Mayerhofer A; Kovar KA; Schmidt WJ Neurosci Lett; 2002 Sep; 330(3):280-4. PubMed ID: 12270646 [TBL] [Abstract][Full Text] [Related]
38. EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. II. Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA). Poklis A; Fitzgerald RL; Hall KV; Saady JJ Forensic Sci Int; 1993 Apr; 59(1):63-70. PubMed ID: 8099337 [TBL] [Abstract][Full Text] [Related]
39. Solid-phase extraction for profiling of ecstasy tablets. Rashed AM; Anderson RA; King LA J Forensic Sci; 2000 Mar; 45(2):413-7. PubMed ID: 10782963 [TBL] [Abstract][Full Text] [Related]
40. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. Peters FT; Schaefer S; Staack RF; Kraemer T; Maurer HH J Mass Spectrom; 2003 Jun; 38(6):659-76. PubMed ID: 12827635 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]